Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Michelle, Brauer"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gary R, Lichtenstein, Ahva, Shahabi, Seth A, Seabury, Darius N, Lakdawalla, Oliver Díaz, Espinosa, Sarah, Green, Michelle, Brauer, Robert N, Baldassano
Publikováno v:
Gastroenterol Hepatol (N Y)
Patients with Crohn’s disease (CD) or ulcerative colitis (UC) have high morbidity rates owing to debilitating intestinal complications and extraintestinal manifestations (EIMs). We retrospectively identified patients in the Truven MarketScan databa
Publikováno v:
Journal of Comparative Effectiveness Research. 9:327-340
Aim: This study examines how chimeric antigen receptor T-cell (CAR-T) therapy’s incremental effectiveness and cost–effectiveness profile fits into the recent history of anticancer treatments. Materials & methods: We conducted graphical and multiv
Publikováno v:
Circulation. 142
Introduction: The PIONEER-HF trial demonstrated superior efficacy of sacubitril/valsartan over the angiotensin-converting-enzyme inhibitor (ACEi) enalapril in treating patients with acute decompensated heart failure (ADHF) after stabilization in the
Publikováno v:
Journal of medical economics. 23(12)
To understand the financial impact of health system adoption of novel heart failure medications under US alternative payment models (APMs).This study used a decision tree model to assess the financial impact of health system adoption of sacubitril/va
Autor:
Michelle Brauer, Lisa Mucha, Schiffon L Wong, Adeline Durand, Emma van Eijndhoven, Jason Shafrin, Rebecca Kee, Joanna P. MacEwan
Aims: Model how moving from current disease-modifying drug (DMD) prescribing patterns for relapsing-remitting multiple sclerosis (RRMS) observed in the United Kingdom (UK) to prescribing patterns based on patient preferences would impact health outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffa217963cb634a35d97265339728e53
Autor:
Michael O’Neil, Rick Hockett, Jason Shafrin, Anupam B. Jena, Katalin Bognar, Lauren Zhao, Michelle Brauer
Publikováno v:
Journal of Medical Economics. 21:1057-1066
Improvements in information technology have granted the recent development of rapid, cloud-enabled, onsite laboratory testing for rheumatoid arthritis (RA). This study aims to quantify the value to payers of such technologies.To calculate the value o
Autor:
Mina Kabiri, Michelle Brauer, Dana P. Goldman, Jeffrey Sullivan, Thomas M. Gill, Jason Shafrin
Publikováno v:
Value in Health. 21:792-798
Background Mobility impairments have substantial physical and mental health consequences, resulting in diminished quality of life. Most studies on the health economic consequences of mobility limitations focus on short-term implications. Objectives T
Autor:
Julia, Thornton Snider, Michelle, Brauer, Rebecca, Kee, Katharine, Batt, Pinar, Karaca-Mandic, Jie, Zhang, Dana P, Goldman
Publikováno v:
The American journal of managed care. 25(8)
To date, breakthrough chimeric antigen receptor (CAR) T-cell therapies, such as tisagenlecleucel, indicated for pediatric acute lymphoblastic leukemia (pALL) and diffuse large B-cell lymphoma (DLBCL), and axicabtagene ciloleucel, indicated for DLBCL,